EVRY, France and INGOLSTADT, Germany, Jan. 4, 2016 (GLOBE NEWSWIRE) -- Global Bioenergies (Alternext Paris: ALGBE) and Audi announce the signature of a new collaboration agreement to further broaden the feedstock flexibility of Global Bioenergies' Isobutene process.
The two companies recently announced the delivery by Global Bioenergies to Audi of a first batch of isobutene-derived isooctane, a premium drop-in fuel for gasoline engines. Global Bioenergies had produced isobutene using its pilot plant located on the agri-business site of Pomacle, France. The isobutene was then shipped to Germany and converted into isooctane. The initial collaboration, expected to end in 2016, also encompasses the delivery of larger batches that will allow Audi to run comprehensive engine testing and thus validate the specifications of Global Bioenergies' isooctane. Global Bioenergies will use its Demo plant, presently under construction on the site of the Leuna refinery, to produce these batches.
The now signed extension and enhancement of the collaboration agreement between the two companies focuses on making Global Bioenergies' technology accessible for non-biomass derived carbon sources such as CO2 or CO and energy sources such as green hydrogen produced from wind or solar energy.
Reiner Mangold, Head of sustainable product development at Audi declares: "The two principal next steps we see on the path towards commercialization of Audi e-benzin consist in upscaling Global Bioenergies' technology towards the demonstration scale, which is on its way in Leuna, as well as ensuring the technology can work with non-biomass derived feedstock according to Audi's e-fuel strategy."
Marc Delcourt, CEO at Global Bioenergies adds: "Isooctane is a premium gasoline, displaying both a high octane rating and a low volatility. Targeting its large scale production will benefit from extending our process compatibility to various feedstocks that do not compete with neither the food nor the feed production."
This new agreement includes the payment of upfront and milestone fees, as well as the possibility for Audi to acquire shares of Global Bioenergies corresponding to less than 1% of its capital.
About GLOBAL BIOENERGIES
Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the performances of its process, operates its industrial pilot, has begun the construction of its demo plant in Germany, and prepares the first full-scale plant through a Joint-Venture with Cristal Union, named IBN-One. The company also replicated its achievement to propylene and butadiene, two members of the gaseous olefins family, key molecules at the heart of petrochemical industry. Global Bioenergies is listed on Alternext, Euronext Paris (FR0011052257 - ALGBE).
Should you like to be kept informed, subscribe to our news feed on
www.global-bioenergies.com
Follow us on Twitter: @GlobalBioenergi
Contact
GLOBAL BIOENERGIES
Thomas BUHL
Head of Business Development
Phone: +33 (0)1 64 98 20 50
Email: [email protected]
PRESS RELEASE http://hugin.info/166909/R/1976461/723358.pdf
HUG#1976461


Luxury Car Sales in the Middle East Take a Hit Amid Iran War
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
First Western Ship Transits Strait of Hormuz Since Iran War Began
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Apple Turns 50: From Garage Startup to AI Crossroads 



